Bayer: Pulmonary Embolism trials

The registry lists 15 Pulmonary Embolism studies with Bayer as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 2 2Phase 3 4No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)CompletedNCT02064439Phase 3Results posted
• Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 InducerCompletedNCT00786422Phase 2Results posted
• Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill PatientsCompletedNCT00571649Phase 3Results posted
• Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE StudyCompletedNCT00439777Phase 3Results posted
• Xarelto for Real Life Anticoagulation in Pulmonary Embolism (PE) in ChinaCompletedNCT03410706
• Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision AlgorithmWithdrawnNCT02900404
• A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active CancerCompletedNCT02742623
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)CompletedNCT02468102
• Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care TherapyCompletedNCT02210819
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)CompletedNCT01947998
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)CompletedNCT01947985
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)CompletedNCT01947959
• Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) IndicationCompletedNCT01805544
• Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) PatientsCompletedNCT01516814Phase 3
• Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)CompletedNCT00839163Phase 2